Comparison of unilateral biportal and percutaneous endoscopic discectomy in treating far lateral lumbar disc herniation

单侧双通道椎间盘切除术与经皮内镜椎间盘切除术治疗远外侧腰椎间盘突出症的比较

阅读:1

Abstract

OBJECTIVES: This study aims to investigate the clinical efficacy of managing far lateral lumbar disc herniation (FLLDH) through two surgical approaches: unilateral biportal endoscopy (UBE) and percutaneous endoscopic lumbar discectomy (PELD). PATIENTS AND METHODS: Between December 2019 and September 2024, a total of 45 patients (18 males, 27 females; mean age: 59.76±11.82 years; range, 31 to 89 years) who were diagnosed with FLLDH were retrospectively analyzed. Based on the surgical technique used, the patients were randomly divided into two groups: the PELD group (n=17) and the UBE group (n=28). Perioperative indicators, including operative time, postoperative hospital stay and mean fluoroscopy times, were recorded. Pre- and postoperative assessments were conducted at the time of admission and at one, three, and six months after surgery, using the Visual Analog Scale (VAS) and the Oswestry Disability Index (ODI) scores. The modified MacNab criteria were used to assess patient satisfaction. RESULTS: Both groups demonstrated a reduction in VAS and ODI scores after surgery (p<0.05). However, no statistically significant differences were observed between the groups at one, three, or six months postoperatively. Operative times were also comparable, with the UBE group mean 97.39±26.78 min and the PELD group 88.18±27.52 min. The postoperative length of hospital stay was similar, with the UBE group staying a mean of 3.93±1.81 days and the PELD group 3.06±1.21 days (p>0.05). The mean fluoroscopy times were significantly lower in the UBE group, with 6.25±1.30 times compared to 16.76±6.02 times in the PELD group (p<0.05). CONCLUSION: Our study results suggest that UBE is a viable alternative to PELD for treating FLLDH, offering comparable clinical outcomes with reduced radiation exposure.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。